📰 Deborah Elson News
Deborah Elson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Deborah Elson. Real-time updates on events, politics, business and more.
May 23, 2024
Financing includes participation from new and existing investors Strengthens balance sheet, with pro forma cash position of approximately $1.0 billion, extending expected financial runway into the
May 23, 2024
Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational
May 23, 2024
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--May 23, 2024--
February 28, 2024
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Feb 28, 2024--
May 11, 2021
Published: May 11, 2021 - Enrollment Now Underway in Multiple Solid Tumor and Hematologic Malignancy Expansion Cohorts in Phase 1 Trial of Oral PRMT5 Inhibitor PRT543 - - Initial Clinical Data Readouts for Lead Oral PRMT5 Inhibitors PRT543 and PRT811 Expected in 2H21 - - Dose Escalation Ongoing in Phase 1 Trial of Oral MCL1 Inhibitor PRT1419, with Dose Expansion Cohorts on Track to be Added in 2H21 - WILMINGTON, Del., May 11, 2021 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD)...